Global Biosimulation Market

1
MarketsandMarkets Presents
Global Biosimulation Market
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
2
The report Global Biosimulation Market
(Insilico Technology Markets for Drug
Development) (2012 - 2017) defines and segments
the global biosimulation market with analysis of
forecasting of the global revenue and
applications revenue for biosimulation. It also
identifies driving and restraining factors for
the global biosimulation market with analysis of
trends, opportunities, challenges, strengths,
weakness and threats. The market is segmented and
revenue is forecasted on the basis of major
region such as North America, Europe, Asia and
Rest of the World. Market is segmented and
revenues are forecasted on the basis of
application and region. Browse gtgt Browse more
than 51 market data tables/figures spread through
130 pages and in-depth TOC on Global
Biosimulation Market (Insilico Technology Markets
for Drug Development) (2012 - 2017).
http//www.marketsandmarkets.com/Market-Reports/b
iosimulation-market-838.html
                   
                    

3

Biosimulation Market Share, By Geography Geography
Source MarketsandMarkets Analysis
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
4
Biosimulation is one the fastest growing
technology applied in drug discovery and
development process. The decline in output and
increase in cost in RD for new drug discovery
and development is a major growth factor for the
biosimulation. With many drug candidates failing
in the late development stages, pharmaceutical
companies are under pressure to reduce cost spent
by focusing only on specific experiments,
Biosimulation aids in focusing on potentially
safe drug candidate and developing it into a
successful drug. The key growth area is
application of Pharmacokinetic/pharmacodynamic
(PKPD) modeling in pre clinical development it is
the most widely used model in drug development
process which is driving the growth of
biosimulation.
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
5
Modelling and simulation are widely used across
the drug development process in large and small
pharmaceutical companies. Pharmaceutical
companies realize that integrating existing
knowledge and using quantitative simulation
methods offer significant savings in time, money
and material over expensive in vitro and in vivo
studies. The global market for biosimulation in
terms of revenue was estimated to be worth 432.0
million in 2011 and is expected to reach 1.2
billion by 2017, growing at a CAGR of 18.50 from
2012 to 2017.
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
6
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html
7
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/bi
osimulation-market-838.html